Enanta Pharmaceuticals, Inc., located in Watertown, Massachusetts, is a biotechnology firm dedicated to the discovery and development of groundbreaking small molecule therapeutics aimed at combating viral infections and liver diseases. The company boasts a robust pipeline that includes candidates specifically targeting hepatitis B and other viral pathogens, underscoring its extensive scientific expertise and innovative drug development capabilities. With a strategic focus on advancing its proprietary programs, Enanta is well-positioned to make a meaningful impact in the fields of infectious disease management and liver health, offering potential enhancements in patient care and treatment outcomes.